CA2389110A1 - Regulation de l'expression genetique au moyen d'agents neuroleptiques - Google Patents

Regulation de l'expression genetique au moyen d'agents neuroleptiques Download PDF

Info

Publication number
CA2389110A1
CA2389110A1 CA002389110A CA2389110A CA2389110A1 CA 2389110 A1 CA2389110 A1 CA 2389110A1 CA 002389110 A CA002389110 A CA 002389110A CA 2389110 A CA2389110 A CA 2389110A CA 2389110 A1 CA2389110 A1 CA 2389110A1
Authority
CA
Canada
Prior art keywords
seq
polypeptide
polynucleotide
sequence
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002389110A
Other languages
English (en)
Inventor
Elizabeth A. Thomas
J. Gregor Sutcliffe
Thomas M. Pribyl
Brian Hilbush
Karl W. Hasel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Digital Gene Technologies Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2389110A1 publication Critical patent/CA2389110A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

L'invention concerne des polynucléotides, des polypeptides, des trousses et des méthodes liés à des gènes exprimés dans les système nerveux central et régulés par des neuroleptiques.
CA002389110A 1999-10-26 2000-10-26 Regulation de l'expression genetique au moyen d'agents neuroleptiques Abandoned CA2389110A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16137999P 1999-10-26 1999-10-26
US60/161,379 1999-10-26
PCT/US2000/029690 WO2001030972A2 (fr) 1999-10-26 2000-10-26 Regulation de l'expression genetique au moyen d'agents neuroleptiques

Publications (1)

Publication Number Publication Date
CA2389110A1 true CA2389110A1 (fr) 2001-05-03

Family

ID=22580950

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002389110A Abandoned CA2389110A1 (fr) 1999-10-26 2000-10-26 Regulation de l'expression genetique au moyen d'agents neuroleptiques

Country Status (6)

Country Link
EP (1) EP1226152A2 (fr)
JP (1) JP2003533970A (fr)
AU (1) AU1349801A (fr)
CA (1) CA2389110A1 (fr)
MX (1) MXPA02004241A (fr)
WO (1) WO2001030972A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960439B2 (en) 1999-06-28 2005-11-01 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
AU2002318112B2 (en) 2001-04-10 2007-12-06 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
KR20040064275A (ko) 2001-11-09 2004-07-16 소스 프리시전 메디슨, 인코포레이티드 유전자 발현 프로파일을 이용한 질병의 동정, 모니터링,치료 및 생물학적 상태의 확인

Also Published As

Publication number Publication date
EP1226152A2 (fr) 2002-07-31
MXPA02004241A (es) 2002-10-17
WO2001030972A2 (fr) 2001-05-03
AU1349801A (en) 2001-05-08
JP2003533970A (ja) 2003-11-18
WO2001030972A3 (fr) 2002-05-10

Similar Documents

Publication Publication Date Title
US20080051338A1 (en) 98 Human Secreted Proteins
US20090088555A1 (en) 44 Human Secreted Proteins
US20080146505A1 (en) 47 Human Secreted Proteins
JP2001524814A (ja) ２８種類のヒト分泌タンパク質
US20090305991A1 (en) 33 Human Secreted Proteins
JP2002501738A (ja) ６７個のヒト分泌タンパク質
JP2002506625A (ja) サイトカインレセプター共通γ鎖様
US20070190612A1 (en) 31 Human Secreted Proteins
US20070010664A1 (en) Gene expression in the central nervous system regulated by neuroleptic agents
JP2002506875A (ja) 第１８ｐ染色体関連障害の診断及び治療のための方法及び組成物
CA2389110A1 (fr) Regulation de l'expression genetique au moyen d'agents neuroleptiques
WO2001029179A2 (fr) Regulation de l'expression genetique par des neuromodulateurs
US20030215817A1 (en) Modulation of gene expression in formation of fatty atherosclerotic lesions
WO2001034770A2 (fr) Expression genetique modulee par l'activation de microglies ou de macrophages
US20060142233A1 (en) Gene expression and genetic changes implicated in alcoholism
CA2309677A1 (fr) Nouveaux gene et proteine exprimes dans les tissus nerveux et pancreatiques
CA2395054A1 (fr) Polynucleotides, polypeptides et anticorps humains
WO2002026936A2 (fr) Expression genetique dans le systeme nerveux central regule par des neuroleptiques
US20030228677A1 (en) AMID protein, nucleic acid molecules, and uses thereof
WO2001012647A1 (fr) Expression genique modulee en tumorigenese de l'ataxie-telangiectasie
WO2002042420A2 (fr) Modulation de l'expression de genes lors de l'hyperplasie de l'intima de l'artere carotide
WO2002031114A2 (fr) Expression genique module dans l'ileite
AU2001232958A1 (en) Modulation of gene expression in formation of fatty atherosclerotic lesions
WO2002081726A2 (fr) Modulation de l'expression genetique dans des modeles genetiques murins de l'atherosclerose
MXPA01012717A (es) Expresion genica modulada en inflamacion gastrointestinal.

Legal Events

Date Code Title Description
FZDE Dead